Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA, 10.1001/jama.2020.2648
Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7
Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3
Bhatraju, 2020, Covid-19 in critically ill patients in the Seattle region–case series, N Engl J Med, 10.1056/NEJMoa2004500
Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 30, 2, 10.1038/s41422-020-0282-0
Liu, 2020, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov, 6, 16, 10.1038/s41421-020-0156-0
Tang, 2020, Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial, medRxiv
Chen, 2020, Favipiravir versus arbidol for COVID-19: a randomized clinical trial, medRxiv
Shen, 2020, Treatment of 5 critically ill patients with COVID-19 with convalescent plasma, JAMA, 10.1001/jama.2020.4783
Cao, 2020, A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19, N Engl J Med, 10.1056/NEJMoa2001282
Lo, 2017, GS-5734 and its parent nucleoside analog inhibit filo-, pneumo-, and paramyxoviruses, Sci Rep, 7, 10.1038/srep43395
Sheahan, 2017, Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses, Sci Transl Med, 9, 10.1126/scitranslmed.aal3653
Warren, 2016, Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys, Nature, 531, 381, 10.1038/nature17180
Brown, 2019, Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase, Antiviral Res, 169, 10.1016/j.antiviral.2019.104541
Sheahan, 2020, Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV, Nat Commun, 11, 222, 10.1038/s41467-019-13940-6
de Wit, 2020, Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection, Proc Natl Acad Sci USA, 117, 6771, 10.1073/pnas.1922083117
Pizzorno, 2020, Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia, bioRxiv
Williamson, 2020, Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2, bioRxiv
Mulangu, 2019, A randomized, controlled trial of Ebola virus disease therapeutics, N Engl J Med, 381, 2293, 10.1056/NEJMoa1910993
Grein, 2020, Compassionate use of remdesivir for patients with severe Covid-19, N Engl J Med, 10.1056/NEJMoa2007016
Holshue, 2020, First case of 2019 novel coronavirus in the United States, N Engl J Med, 382, 929, 10.1056/NEJMoa2001191
Whitehead, 1983, Group sequential clinical trials with triangular continuation regions, Biometrics, 39, 227, 10.2307/2530822
Gilead Sciences. Investigator's brochure of remdesivir, 5th edition. Feb 21, 2020.
Jacobs, 2016, Late Ebola virus relapse causing meningoencephalitis: a case report, Lancet, 388, 498, 10.1016/S0140-6736(16)30386-5
Agostini, 2018, Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease, MBio, 9, e00221, 10.1128/mBio.00221-18
Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients, J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006